載入...
PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer
Abstract Background Bladder cancers have been characterized as a tumor group in which the immunological response is relatively well preserved. Programmed death ligand 1 (PD-L1, B7-H1, CD274) has been shown to be expressed in several malignancies, including bladder cancer. However, the clinicopatholo...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
BMC
2018-11-01
|
叢編: | BMC Urology |
主題: | |
在線閱讀: | http://link.springer.com/article/10.1186/s12894-018-0414-8 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|